SMTL ID : 6i16.1

CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 15

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.1: 6 residues within 4Å: Chain A: W.101, V.134, Y.186, T.213, L.214 Ligands: H0B.2 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:V.134, A:L.214 Hydrogen bonds: A:V.134, A:L.214 Water bridges: A:V.134, A:V.134

1 x H0B: 6-[(3,4-dichlorophenyl)methyl]-~{N}-(1-methylpyrazol-4-yl)-5-oxidanylidene-1,6-naphthyridine-8-carboxamide(Non-covalent)

H0B.2: 15 residues within 4Å: Chain A: F.14, L.48, Q.50, G.56, S.57, A.58, I.93, W.101, L.103, V.134, L.214, E.215, F.216, R.217 Ligands: ACT.1 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.48, A:L.48, A:I.93, A:I.93, A:F.216 Hydrogen bonds: A:S.57, A:F.216 Water bridges: A:R.217 pi-Stacking: A:F.14, A:W.101

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Francis, S. et al., Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents. Bioorg.Med.Chem.Lett. (2019)

Release Date

2019-02-27

Peptides

Fascin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Fascin

Related Entries With Identical Sequence